Poolbeg Pharma announces expansion of POLB 001 into oncology
By:
News Direct
January 18, 2023 at 08:10 AM EST
--News Direct--
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing that the company has submitted a patent application for the use of POLB 001 in a new oncological indication. Skillington explains the reasons for the strategic expansion and reveals more about his vision for the molecule in the long term.

Contact Details
Proactive UK Ltd
+44 20 7989 0813
View source version on newsdirect.com: https://newsdirect.com/news/poolbeg-pharma-announces-expansion-of-polb-001-into-oncology-711615119
More News
View More
MP Materials Stock Soared After Earnings—Here’s the Real Reason ↗
November 22, 2025
Via MarketBeat
Why Palantir Slide May Be a Setup for a Long-Term Opportunity ↗
November 22, 2025
Via MarketBeat
Attention Income Investors: This REIT Is on Sale ↗
November 22, 2025
Rocket Lab Just Had Its First Real Crash—The Rebound Could Be Bigger ↗
November 22, 2025
Via MarketBeat
Tickers
RKLB
MarketBeat Week in Review – 11/17 - 11/21 ↗
November 22, 2025
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>